Netherlands· NL-c5d83dbc6ebe
Brinavess 20 mg / ml, concentraat voor oplossing voor infusie
A vernakalant product containing vernakalanthydrochloride 0-water, registered in Netherlands by Advanz Pharma Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Vernakalant is registered in 12 of 19 countries.
Countries holding a registration under ATC C01BG11 (vernakalant), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Vernakalant · ATC C01BG11
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- VERNAKALANTHYDROCHLORIDE 0-WATER
- Manufacturer
- Advanz Pharma Limited
- Country
- Netherlands (NL)
- ATC code
- C01BG11
- ATC class
- Vernakalant
- Defined daily dose
- 0.2 g, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/10/645
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vernakalant in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBRINAVESSADVANZ PHARMA Limited, Dublin
- BelgiumBrinavess 20 mg/mlAdvanz Pharma
- SpainBRINAVESS 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSIONAdvanz Pharma Limited
- FinlandBRINAVESSAdvanz Pharma Limited
- United KingdomBrinavess 500mg/25ml concentrate for solution for infusion vialsAdvanz Pharma
- IrelandBRINAVESS 20 mg/ml concentrate for solution for infusionCorrevio
- IcelandBrinavessADVANZ PHARMA Limited
- PolandBrinavessCorrevio
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Brinavess
- Liechtenstein · Brinavess
- Norway · Brinavess
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1bed8254-ed3b-428f-8d3b-15d585505d7c GET /v1/drugs/1bed8254-ed3b-428f-8d3b-15d585505d7c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/brinavess-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Vernakalant",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp105811",
"excipients": [
"CITROENZUUR 1-WATER (E 330)",
"NATRIUMCHLORIDE",
"NATRIUMHYDROXIDE (E 524)",
"STIKSTOF (HEAD SPACE) (E 941)",
"WATER VOOR INJECTIE"
],
"substances": [
"VERNAKALANTHYDROCHLORIDE 0-WATER"
],
"leaflet_url": null,
"authorised_at": "2010/09/01",
"procedure_number": "EMEA/H/C/001215",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/10/645",
"additional_monitoring": "N"
}See everything about vernakalant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.